Levicept Competitors and Similar CompaniesClear all

Levicept's competitors and similar companies include ROCAtest and Akebia Therapeutics.
Levicept
Levicept
Levicept Ltd. develops biological agent for the treatment of chronic pain
ROCAtest
ROCAtest
ROCAtest (also known as Abcodia) is an innovative biotech company engaged in the validation and discovery of molecular biomarkers.
Akebia Therapeutics
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Founding Date
Founding Date
2012
Founding Date
2010
Founding Date
2007
Type
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Sandwich, GB HQ
Locations
Leeds, GB HQ
Royston, GB
Boston, US
Memphis, US
Locations
Cambridge, US HQ
Employees
Employees
N/A
Employees
29
Employees
324187% increase

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
£568.3k (FY, 2015)
Revenue (est.)
$236.2m (FY, 2025)
Cost of goods
Cost of goods
£3.3m (FY, 2015)
Cost of goods
£28.5k (FY, 2015)
Cost of goods
$39.5m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
£539.7k (FY, 2015)
Gross profit
$196.7m (FY, 2025)
Net income
Net income
(£3.7m) (FY, 2015)
Net income
(£2.7m) (FY, 2015)
Net income
($5.3m) (FY, 2025)

Funding

Latest funding round
Latest funding round
$ 3.9m (over 11 years ago)
Latest funding round
$ 8.3m (about 11 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 16.1m
Total funding raised
$ 17m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

ROCAtest
HQ
Leeds, GB
Employees
29

ROCAtest (also known as Abcodia) is an innovative biotech company engaged in the validation and discovery of molecular biomarkers.

View company
Akebia Therapeutics
HQ
Cambridge, US
Employees
324

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

View company